As shown in Figure 1(a), area under receiver operating curve (AUROC) analysis assessing serum VEGF-C as a diagnostic tool for discriminating ovarian cancer from benign ovarian diseases and healthy controls was 0.826 (95% CI, 0.773–0.879) compared with 0.760 (95% CI, 0.697–0.822) for CA125. The gene discussed is VEGFC; the disease is ovarian cancer.